Correlation of bevacizumab-induced hypertension and outcomes of metastatic colorectal cancer patients treated with bevacizumab: a systematic review and meta-analysis

BACKGROUND: With the wide application of targeted drug therapies, the relevance of prognostic and predictive markers in patient selection has become increasingly important. Bevacizumab is commonly used in combination with chemotherapy in the treatment of metastatic colorectal cancer. However, there...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Jun, Ma, Hong, Huang, Fang, Zhu, Dichao, Bi, Jianping, Ke, Yang, Zhang, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220777/
https://www.ncbi.nlm.nih.gov/pubmed/24283603
http://dx.doi.org/10.1186/1477-7819-11-306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220777/
https://www.ncbi.nlm.nih.gov/pubmed/24283603
http://dx.doi.org/10.1186/1477-7819-11-306

Ejemplares similares